Bart Jan Kullberg Selected Research

Atherosclerosis

7/2002	Native LDL potentiate TNF alpha and IL-8 production by human mononuclear cells.
1/2002	Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bart Jan Kullberg Research Topics

Disease

36	Infections 03/2024 - 01/2002
19	Candidiasis (Moniliasis) 02/2022 - 01/2002
11	Lyme Disease (Disease, Lyme) 10/2023 - 10/2014
7	Mycoses (Diseases, Fungus) 01/2023 - 04/2004
7	Sepsis (Septicemia) 12/2019 - 12/2002
6	Aspergillosis 01/2018 - 10/2004
6	Inflammation (Inflammations) 01/2017 - 01/2002
5	Invasive Candidiasis 11/2023 - 01/2017
5	Candidemia 01/2019 - 08/2004
5	Invasive Fungal Infections 03/2014 - 10/2004
4	Necrosis 02/2022 - 11/2003
4	Fever (Fevers) 07/2019 - 01/2005
4	Abscess 06/2017 - 12/2002
4	Crohn Disease (Crohn's Disease) 04/2008 - 07/2004
2	Foreign Bodies (Foreign Body) 07/2019 - 03/2012
2	Bacteremia 07/2019 - 03/2012
2	Neutropenia 01/2018 - 01/2017
2	Cryptococcal Meningitis 11/2004 - 10/2004
2	Atherosclerosis 07/2002 - 01/2002
1	Bacterial Infections (Bacterial Infection) 04/2022
1	Critical Illness (Critically Ill) 04/2022
1	Liver Failure 04/2022
1	Anastomotic Leak 04/2022
1	Epstein-Barr Virus Infections 02/2022
1	Cytomegalovirus Infections (Inclusion Disease) 02/2022
1	Drug-Related Side Effects and Adverse Reactions 02/2022
1	Herpes Simplex 02/2022
1	Herpesviridae Infections (Herpesvirus Infection) 02/2022
1	Cutaneous Candidiasis 02/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2022
1	Arthritis (Polyarthritis) 05/2020
1	Endocarditis 07/2019
1	Deglutition Disorders (Dysphagia) 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Aspiration Pneumonia 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Cytokine Release Syndrome 01/2018
1	Borrelia Infections 12/2016

Drug/Important Bio-Agent (IBA)

19	CytokinesIBA 01/2018 - 01/2002
11	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 10/2014
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008 - 01/2002
7	Interleukin-18 (Interleukin 18)IBA 06/2006 - 04/2002
6	InterleukinsIBA 02/2022 - 04/2002
6	Interferon-gamma (Interferon, gamma)IBA 06/2017 - 12/2002
5	Interleukin-10 (Interleukin 10)IBA 03/2024 - 07/2004
5	Interleukin-12 (IL 12)IBA 02/2022 - 04/2002
5	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2009 - 05/2002
4	Voriconazole (Vfend)FDA LinkGeneric 01/2019 - 08/2011
3	Caspofungin (Cancidas)FDA Link 11/2023 - 01/2019
3	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2014 - 12/2003
3	Pattern Recognition ReceptorsIBA 03/2011 - 08/2008
3	Lipoproteins (Lipoprotein)IBA 01/2009 - 08/2004
2	RezafunginIBA 11/2023 - 01/2023
2	EchinocandinsIBA 11/2023 - 01/2023
2	Interleukin-17 (Interleukin 17)IBA 02/2022 - 10/2010
2	VaccinesIBA 05/2020 - 01/2010
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019 - 03/2016
2	Doxycycline (Periostat)FDA LinkGeneric 01/2019 - 03/2016
2	Clarithromycin (Biaxin)FDA LinkGeneric 01/2019 - 03/2016
2	Interleukin-1beta (Interleukin 1 beta)IBA 01/2018 - 05/2006
2	Antifungal AgentsIBA 03/2014 - 12/2003
2	Fluconazole (Zonal)FDA LinkGeneric 08/2011 - 12/2003
2	Biomarkers (Surrogate Marker)IBA 02/2011 - 11/2010
2	AntibodiesIBA 04/2009 - 07/2003
2	LipopolysaccharidesIBA 01/2009 - 04/2008
2	Apolipoproteins E (ApoE)IBA 01/2009 - 08/2004
2	NucleotidesIBA 04/2008 - 04/2006
2	LigandsIBA 04/2008 - 07/2004
2	Toll-Like Receptor 4IBA 03/2006 - 07/2003
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2005 - 12/2003
2	InterferonsIBA 11/2004 - 04/2002
2	Lymphotoxin-alpha (Lymphotoxin)IBA 12/2002 - 01/2002
1	Ustekinumab (CNTO 1275)FDA Link 02/2022
1	Infliximab (Remicade)FDA Link 02/2022
1	secukinumabIBA 02/2022
1	ProteomeIBA 02/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2019
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2019
1	isavuconazoleIBA 01/2019
1	PlatinumIBA 01/2019
1	Complement Receptors (Complement Receptor)IBA 01/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2018
1	CoagulaseIBA 01/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2017
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Anidulafungin FDA Link 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2016

Therapy/Procedure

20	Therapeutics 02/2022 - 04/2003
8	Immunotherapy 01/2018 - 04/2004
4	Aftercare (After-Treatment) 10/2023 - 07/2021
2	Immunomodulation 09/2005 - 12/2003
1	Transplantation 01/2023
1	Parenteral Nutrition 04/2022
1	Duration of Therapy 07/2019
1	Chemoradiotherapy 01/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Debridement 01/2017